Follow-up
Further Outpatient Care
- Gonococcal cultures are recommended 4-8 weeks after standard treatment or one week after alternative regimens are used.
- Routine testing for chlamydial eradication is not indicated after treatment; however, repeat testing may be worthwhile after 1-2 months in patients with a high risk of reinfection to identify inadequate treatment of their partners or new infections.
- Routine annual screening for chlamydial infection is recommended in all sexually active adolescents because of the high prevalence of asymptomatic females.
- Treat sexual partners.
Complications
- Ascending infection
- Arthritis, rash, or both (from disseminated gonorrhea)
Prognosis
- The prognosis is excellent when the patient is compliant.
Patient Education
- Instruct patients to avoid sexual intercourse until treatment efficacy is confirmed.
- Instruct patients how to prevent reinfection by using condoms.
- Recommend prevention counseling to patients with sexually transmitted infections.
- Recommend that patients receive screening for other diseases, including HIV infection and syphilis.
- For excellent patient education resources, visit eMedicine's Women's Health Center. Also, see eMedicine's patient education article Cervicitis.
Miscellaneous
Special Concerns
- Adolescent compliance with the recommended regimen is a notable concern.
- A single dose of azithromycin 1 g PO is effective therapy for chlamydial infections and eliminates the need for ongoing treatment compliance.
- Isolation of gonococci in cervical or vaginal secretions in a child is definitive evidence of sexual abuse.
More on Cervicitis |
| Overview: Cervicitis |
| Differential Diagnoses & Workup: Cervicitis |
| Treatment & Medication: Cervicitis |
Follow-up: Cervicitis |
| References |
| « Previous Page |
References
Marrazzo JM. Mucopurulent cervicitis: no longer ignored, but still misunderstood. Infect Dis Clin North Am. Jun 2005;19(2):333-49, viii. [Medline].
Darville T. Chlamydia. Pediatr Rev. Mar 1998;19(3):85-91. [Medline].
Darville T. Gonorrhea. Pediatr Rev. Apr 1999;20(4):125-8. [Medline].
Simpson T, Oh MK. Urethritis and cervicitis in adolescents. Adolesc Med Clin. Jun 2004;15(2):253-71. [Medline].
Smith KR, Ching S, Lee H, et al. Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic. J Clin Microbiol. Feb 1995;33(2):455-7. [Medline].
CDC, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. Aug 4 2006;55(RR-11):1-94. [Medline]. [Full Text].
CDC. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. Apr 13 2007;56(14):332-6. [Medline]. [Full Text].
Sexually transmitted diseases: gonorrhea, Chlamydia trachomatis, pelvic inflammatory disease and syphilis. In: Emans SJ, Laufer MR, Goldstein DP, et al, eds. Pediatric and Adolescent Gynecology. 4th ed. Philadelphia, PA: Lippincott-Raven; 1998:457-504.
Rome ES. Sexually transmitted diseases: testing and treating. Adolesc Med. Jun 1999;10(2):231-41, vi. [Medline].
Stuart GS, Castano PM. Sexually transmitted infections and contraceptives: selective issues. Obstet Gynecol Clin North Am. 30(4):795-808. [Medline].
Further Reading
Keywords
cervicitis, cervix, gonococcal cervicitis, chlamydial cervicitis, vaginal discharge, sexually transmitted disease, STD, cervical infection, cervical inflammation, cervical erythema, vulvovaginitis, endometritis, salpingitis, tubo-ovarian abscess, perihepatitis, gonorrhea, Neisseria gonorrhea, Chlamydia trachomatis, C trachomatis, Neisseria gonorrhea, N gonorrhea vaginal bleeding, PID, pelvic inflammatory disease
Follow-up: Cervicitis